
PYXS
Healthcare · Biotechnology · $189.0M market cap
$1.580.00 (0.0%)Nov 13, 4:00 PM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +24.4% over 90 days · 30-day revisions 2 up, 0 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 5, 2026 | Before the open | -0.27 | -0.24 | +11.1% |
| Aug 13, 2026 | Before the open | -0.34 | -0.40 | -17.6% |
| May 14, 2026 | Before the open | -0.35 | -0.37 | -5.7% |
| Mar 25, 2026 | Time not confirmed | -0.33 | -0.29 | +11.8% |
| Nov 3, 2025 | Before the open | -0.34 | -0.35 | -2.9% |
| Aug 14, 2025 | After the close | -0.35 | -0.30 | +14.3% |
| May 15, 2025 | Before the open | -0.29 | -0.35 | -20.7% |
| Mar 19, 2025 | Time not confirmed | -0.32 | -1.32 | -312.5% |
| Nov 12, 2024 | Before the open | -0.31 | -0.35 | -12.9% |
| Aug 14, 2024 | After the close | -0.33 | -0.29 | +12.1% |
| May 14, 2024 | Before the open | -0.24 | -0.06 | +75.0% |
| Mar 21, 2024 | Before the open | -0.47 | -0.33 | +29.8% |
| Nov 7, 2023 | After the close | -0.51 |
Pyxis Oncology, Inc., a clinical stage company, engages in the development of therapeutics to treat solid tumors. Its lead antibody-drug conjugates (ADC) product candidate is PYX-201, an investigational novel ADC consisting of human immunoglobulin G1 (IgG1), which is in Phase 1 clinical trial to treat patients with relapsed or refractory solid tumors; PYX-102, an investigational immunotherapeutic targeting KLRG1,…
| -0.56 |
| -9.8% |
| Aug 11, 2023 | Before the open | -0.66 | -0.41 | +37.9% |
| May 11, 2023 | Before the open | -0.90 | -0.55 | +38.9% |
| Mar 22, 2023 | Before the open | -1.01 | -1.04 | -3.0% |
| Nov 1, 2022 | Before the open | -0.89 | -0.85 | +4.5% |
| Aug 15, 2022 | Before the open | -0.92 | -0.79 | +14.1% |
| May 13, 2022 | Before the open | -0.50 | -0.97 | -94.0% |
| Mar 29, 2022 | Before the open | -0.37 | -1.98 | -435.1% |
| Nov 15, 2021 | Before the open | -0.52 | -0.45 | +13.5% |
| Sep 1, 2021 | Time not confirmed | — | -1.02 | — |
| Jun 30, 2021 | Time not confirmed | 0.00 | -15.93 | — |
| Mar 31, 2021 | Time not confirmed | 0.00 | -15.93 | — |
| Jun 30, 2020 | Time not confirmed | 0.00 | -2.74 | — |
| Mar 31, 2020 | Time not confirmed | 0.00 | -2.74 | — |